George Lau to Disease Progression
This is a "connection" page, showing publications George Lau has written about Disease Progression.
Connection Strength
0.136
-
Effect of COVID-19 on patients with compensated chronic liver diseases. Hepatol Int. 2020 Sep; 14(5):701-710.
Score: 0.055
-
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol. 2020 08; 73(2):451-453.
Score: 0.054
-
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score. Clin Infect Dis. 2020 09 12; 71(6):1393-1399.
Score: 0.014
-
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020 Sep; 14(5):690-700.
Score: 0.014